Bioactive Lipid Technology
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
971
NCT03676036
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2015
Completion: Jul 31, 2018
NCT02673593
Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects
Phase: Phase 1
Start: Jul 31, 2015
Completion: Dec 31, 2015
NCT03676933
Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis
Start: Oct 31, 2015
Completion: Apr 25, 2016
NCT02925793
Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)
Start: Dec 31, 2016
NCT02864498
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
Start: Jan 31, 2017
Completion: Jun 30, 2018
NCT03817190
Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
Start: Sep 19, 2019
Completion: Sep 3, 2020
Loading map...